Critical Care of Persons Infected with the Human Immunodeficiency Virus

被引：9

作者：

Ganesan, Anuradha ^{[1
]}

Masur, Henry ^{[2
]}

机构：

[1] Uniformed Serv Univ Hlth Sci, Walter Reed Natl Mil Med Ctr, Div Infect Dis, Dept Med, Bethesda, MD 20889 USA

[2] NIH, Ctr Clin, Dept Crit Care Med, Bethesda, MD 20892 USA

来源：

CLINICS IN CHEST MEDICINE | 2013年 / 34卷 / 02期

基金：

美国国家卫生研究院;

关键词：

ICU; HIV; AIDS; Antiretroviral therapy; ACTIVE ANTIRETROVIRAL THERAPY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RECONSTITUTION INFLAMMATORY SYNDROME; LIVER-RELATED DEATHS; ACUTE-RENAL-FAILURE; INTENSIVE-CARE; HIV-INFECTION; OPPORTUNISTIC INFECTIONS; CEREBROSPINAL-FLUID; TOXOPLASMIC ENCEPHALITIS;

D O I：

10.1016/j.ccm.2013.01.011

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Antiretroviral therapy (ART) has transformed the prognosis for patients infected with the human immunodeficiency virus (HIV). With effective ART, these individuals can expect to live almost as long as their HIV-negative counterparts. Given that more than a million people infected with HIV currently live in the United States, the likelihood that the practicing intensivist will manage a patient infected with HIV is high. This review discusses the challenges associated with management of critically ill patients infected with HIV, including the immune reconstitution inflammatory syndrome (a complication associated with ART initiation), ART-related toxicities, and the management of some common opportunistic infections.

引用

页码：307 / +

页数：18

共 80 条

[1] Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era
Abgrall, S
Rabaud, C
Costagliola, D
[J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (10) : 1747 - 1755
[2] The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma
Aboulafia, DM
[J]. CHEST, 2000, 117 (04) : 1128 - 1145
[3] Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy
Adlakha, A.
Pavlou, M.
Walker, D. A.
Copas, A. J.
Dufty, N.
Batson, S.
Edwards, S. G.
Singer, M.
Miller, R. F.
[J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2011, 22 (09) : 498 - 504
[4] Akgun Kathleen M, 2011, Proc Am Thorac Soc, V8, P301, DOI 10.1513/pats.201009-060WR
[5] [Anonymous], GUIDELINES FOR THE U
[6] [Anonymous], 2012, Reported Tuberculosis in the United States, 2011
[7] Etiologies and outcome of acute respiratory failure in HIV-infected patients
Barbier, Francois
Coquet, Isaline
Legriel, Stephane
Pavie, Juliette
Darmon, Michael
Mayaux, Julien
Molina, Jean-Michel
Schlemmer, Benoit
Azoulay, Elie
[J]. INTENSIVE CARE MEDICINE, 2009, 35 (10) : 1678 - 1686
[8] Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study
Bellini, C.
Keiser, O.
Chave, J-P
Evison, J. M.
Fehr, J.
Kaiser, L.
Weber, R.
Vernazza, P.
Bernasconi, E.
Telenti, A.
Cavassini, M.
[J]. HIV MEDICINE, 2009, 10 (01) : 12 - 18
[9] HIV infection and stroke: current perspectives and future directions
Benjamin, Laura A.
Bryer, Alan
Emsley, Hedley C. A.
Khoo, Saye
Solomon, Tom
Connor, Myles D.
[J]. LANCET NEUROLOGY, 2012, 11 (10) : 878 - 890
[10] Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole
Bicanic, Tihana
Meintjes, Graeme
Wood, Robin
Hayes, Madeleine
Rebe, Kevin
Bekker, Linda-Gail
Harrison, Thomas
[J]. CLINICAL INFECTIOUS DISEASES, 2007, 45 (01) : 76 - 80

← 1 2 3 4 5 6 7 8 →